Home > Category > Signaling Pathways > Immunology & Inflammation > Interleukins > Ixekizumab (Anti-CTLA-8 / IL-17a)

Ixekizumab (Anti-CTLA-8 / IL-17a)

ChemLeader 95+%

Catalog No：CLA1281 CAS No.：1143503-69-8 MDLNo： Formula： MW：

Collect Share

Size	Availability	Price(USD)	VIP Price (USD)	Quantity
1 mg	3-5days	$530.00	Visible after login	- +
5 mg	3-5days	$1150.00	Visible after login	- +
10 mg	3-5days	$1700.00	Visible after login	- +
50 mg	3-5days	$5800.00	Visible after login	- +
100 mg	3-5days	$9800.00	Visible after login	- +

Chemical safety data sheet(MSDS)

Download MSDS

Inquiry Add To Cart

Product Overview
Related documents
Product details
Related literature

Product Overview

Product Name	Ixekizumab (Anti-CTLA-8 / IL-17a)
CAS	1143503-69-8
Storage condition	Store at 2 to 8 °C for 1-2 weeks. Store at -20 °C for 12 months. Store at -80 °C for long term storage. Use a manual defrost freezer and avoid repeated freeze-thaw cycles, away from light.

Product details

Ixekizumab (LY2439821) is a humanized IgG4 monoclonal antibody that selectively binds and neutralizes interleukin IL-17A with a Kd value of <3 pM.Ixekizumab blocks the binding of IL-17A to IL-17RA but not to other IL-17 family members.Ixekizumab is used for the treatment of moderate to severe plaque psoriasis, psoriasis, arthritis and psoriasis. arthritis, and psoriasis.

Related literature

Sorry, there is no relevant literature

Sorry, no related items

History

CLA1281

Ixekizumab (Anti-CTLA-8 / IL-17a)